160 related articles for article (PubMed ID: 37818078)
1. ATXN3 deubiquitinates YAP1 to promote tumor growth.
Wang S; Liu K; Han X; Cheng Y; Zhao E; Brat DJ; Sun Z; Fang D
Am J Cancer Res; 2023; 13(9):4222-4234. PubMed ID: 37818078
[TBL] [Abstract][Full Text] [Related]
2. CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion.
Wang S; Iyer R; Han X; Wei J; Li N; Cheng Y; Zhou Y; Gao Q; Zhang L; Yan M; Sun Z; Fang D
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 38038129
[TBL] [Abstract][Full Text] [Related]
3. ATXN3 functions as a tumor suppresser through potentiating Galectin-9-mediated apoptosis in human colon adenocarcinoma.
Cheng Y; Wang S; Gao Q; Fang D
J Biol Chem; 2024 May; ():107415. PubMed ID: 38815863
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinase ubiquitin-specific peptidase 10 maintains cysteine rich angiogenic inducer 61 expression via Yes1 associated transcriptional regulator to augment immune escape and metastasis of pancreatic adenocarcinoma.
Liu X; Chen B; Chen J; Su Z; Sun S
Cancer Sci; 2022 May; 113(5):1868-1879. PubMed ID: 35271750
[TBL] [Abstract][Full Text] [Related]
5. USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer.
Liu Z; Li J; Ding Y; Ma M; Chen J; Lei W; Li L; Yao Y; Yu X; Zhong M; Liao Q; Fang W; Fan L; Huang C; Zhong H; Wen Q; Fang Z; Chen J; Huang S; Xiong J; Xiang X; Deng J
Oncogene; 2022 Apr; 41(18):2555-2570. PubMed ID: 35318441
[TBL] [Abstract][Full Text] [Related]
6. ATXN3 promotes prostate cancer progression by stabilizing YAP.
Wu L; Ou Z; Liu P; Zhao C; Tong S; Wang R; Li Y; Yuan J; Chen M; Fan B; Zu X; Wang Y; Tang J
Cell Commun Signal; 2023 Jun; 21(1):152. PubMed ID: 37349820
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Ataxin-3 (ATXN3) in the malignant progression of pancreatic cancer via deubiquitinating HDAC6.
Wu X; Zhang X; Liu P; Wang Y
Pancreatology; 2023 Sep; 23(6):630-641. PubMed ID: 37460341
[TBL] [Abstract][Full Text] [Related]
8. YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ERα.
Kim H; Son S; Ko Y; Lee JE; Kim S; Shin I
J Cell Sci; 2021 Jun; 134(11):. PubMed ID: 34096606
[TBL] [Abstract][Full Text] [Related]
9. NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein.
Guo H; Zou J; Zhou L; Zhong M; He Y; Huang S; Chen J; Li J; Xiong J; Fang Z; Xiang X
Front Oncol; 2020; 10():591698. PubMed ID: 33489890
[TBL] [Abstract][Full Text] [Related]
10. ATXN3 Positively Regulates Type I IFN Antiviral Response by Deubiquitinating and Stabilizing HDAC3.
Feng Q; Miao Y; Ge J; Yuan Y; Zuo Y; Qian L; Liu J; Cheng Q; Guo T; Zhang L; Yu Z; Zheng H
J Immunol; 2018 Jul; 201(2):675-687. PubMed ID: 29802126
[TBL] [Abstract][Full Text] [Related]
11. Myosin light chain 9 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells by binding to Yes-associated protein 1 and regulating Hippo signaling.
Feng M; Dong N; Zhou X; Ma L; Xiang R
Bioengineered; 2022 Jan; 13(1):96-106. PubMed ID: 34974798
[TBL] [Abstract][Full Text] [Related]
12. The WW domains dictate isoform-specific regulation of YAP1 stability and pancreatic cancer cell malignancy.
Guo Q; Quan M; Dong J; Bai J; Wang J; Han R; Wang W; Cai Y; Lv YQ; Chen Q; Xu H; Lyu HD; Deng L; Zhou D; Xiao X; De Langhe S; Billadeau DD; Lou Z; Zhang JS
Theranostics; 2020; 10(10):4422-4436. PubMed ID: 32292505
[TBL] [Abstract][Full Text] [Related]
13. ARRDC1 and ARRDC3 act as tumor suppressors in renal cell carcinoma by facilitating YAP1 degradation.
Xiao J; Shi Q; Li W; Mu X; Peng J; Li M; Chen M; Huang H; Wang C; Gao K; Fan J
Am J Cancer Res; 2018; 8(1):132-143. PubMed ID: 29416926
[TBL] [Abstract][Full Text] [Related]
14. Anti-metastatic effect of GV1001 on prostate cancer cells; roles of GnRHR-mediated Gαs-cAMP pathway and AR-YAP1 axis.
Kim JW; Park M; Kim S; Lim SC; Kim HS; Kang KW
Cell Biosci; 2021 Nov; 11(1):191. PubMed ID: 34743733
[TBL] [Abstract][Full Text] [Related]
15. [Doublecortin-like kinase 1 activates Hippo pathway to promote migration, invasion and proliferation of pancreatic cancer cells].
Yan R; Liang ZW; Liu HS; Ge Y; An GY
Zhonghua Zhong Liu Za Zhi; 2023 Jul; 45(7):594-604. PubMed ID: 37462016
[No Abstract] [Full Text] [Related]
16. The ubiquitin-specific peptidase 22 is a deubiquitinase of CD73 in breast cancer cells.
Gregory S; Xu Y; Xie P; Fan J; Gao B; Mani N; Iyer R; Tang A; Wei J; Chaudhuri SM; Wang S; Liu H; Zhang B; Fang D
Am J Cancer Res; 2022; 12(12):5564-5575. PubMed ID: 36628293
[TBL] [Abstract][Full Text] [Related]
17. ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.
Zou H; Chen H; Zhou Z; Wan Y; Liu Z
Cancer Lett; 2019 Dec; 467():19-28. PubMed ID: 31563563
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells.
Diep CH; Zucker KM; Hostetter G; Watanabe A; Hu C; Munoz RM; Von Hoff DD; Han H
PLoS One; 2012; 7(3):e32783. PubMed ID: 22396793
[TBL] [Abstract][Full Text] [Related]
19. Yes-associated protein 1 is activated and functions as an oncogene in meningiomas.
Baia GS; Caballero OL; Orr BA; Lal A; Ho JS; Cowdrey C; Tihan T; Mawrin C; Riggins GJ
Mol Cancer Res; 2012 Jul; 10(7):904-13. PubMed ID: 22618028
[TBL] [Abstract][Full Text] [Related]
20. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
